Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies. [electronic resource]
Producer: 20180326Description: 835-847 p. digitalISSN:- 1538-7836
- Adenine -- analogs & derivatives
- Animals
- Anticoagulants -- administration & dosage
- Antineoplastic Agents -- adverse effects
- Blood Coagulation -- drug effects
- Blood Platelets -- drug effects
- Drug Interactions
- Drug Substitution
- Hemorrhage -- chemically induced
- Humans
- Piperidines
- Platelet Aggregation Inhibitors -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Pyrazoles -- administration & dosage
- Pyrimidines -- administration & dosage
- Risk Assessment
- Risk Factors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.